Try our beta test site
22 studies found for:    therapeutic vaccine | Open Studies | HIV
Show Display Options
Download search resultsDownload the search results for:
therapeutic vaccine | Open Studies | HIV (22 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting iHIVARNA Clinical Trial in HIV Infected Individuals
Condition: HIV Infections
Interventions: Biological: iHIVARNA-01;   Biological: TriMix;   Biological: Placebo
2 Recruiting Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Ad5-gag;   Biological: Placebo
3 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
4 Not yet recruiting An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
Condition: Hiv
Interventions: Biological: GTU-MultiHIV B-clade vaccine;   Biological: MVA HIV-B HIV vaccine;   Biological: Placebo 1: Sodium Chloride;   Biological: Placebo 2:S08 buffer
5 Not yet recruiting REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Condition: HIV/AIDS
Intervention: Biological: REMUNE
6 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Interventions: Biological: Gardasil;   Drug: Placebo
7 Not yet recruiting REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study
Condition: HIV
Intervention: Biological: IR103
8 Recruiting A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals
Condition: Hepatitis C Infection
Interventions: Biological: AdCh3NSmut1;   Biological: MVA-NSmut
9 Recruiting Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV (vCP2438);   Biological: Bivalent Subtype C gp120/MF59;   Biological: Placebo
10 Recruiting Improving Identification of Social Harm Among Substance Abusers in HIV Trials
Conditions: Social Harms in Substance Users in HIV Trials;   Audio Computer Assisted Self-administered Questionnaire
Intervention:
11 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
12 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study
Condition: HIV Infections
Interventions: Drug: Dolutegravir;   Drug: Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamid Fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Rilpivirine;   Drug: Lamivudine;   Drug: tenofovir;   Drug: Emtricitabine;   Drug: Abacavir
13 Recruiting Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
Condition: HIV-1 Infection
Interventions: Drug: Vorinostat;   Biological: AGS-004
14 Recruiting Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Conditions: Liver Diseases, Alcoholic;   Alcoholism;   HIV;   Hepatitis C
Interventions: Other: Integrated Stepped Care (ISC);   Other: Treatment as Usual
15 Recruiting Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Bedaquiline;   Drug: Delamanid;   Drug: Dolutegravir
16 Not yet recruiting Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 Infected Patients
Condition: HIV Infection
Interventions: Biological: DCV3;   Biological: DCV3 with PEG-INF;   Biological: Placebo;   Biological: Placebo with PEG-INF
17 Recruiting Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy
Condition: HIV
Interventions: Drug: triple therapy;   Drug: dual therapy
18 Recruiting Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults
Condition: Rabies
Intervention: Biological: rabies vaccine
19 Recruiting CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Conditions: Bone Marrow Failure Syndrome;   Severe Aplastic Anemia;   Severe Congenital Neutropenia;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Schwachman Diamond Syndrome;   Primary Immunodeficiency Syndromes;   Acquired Immunodeficiency Syndromes;   Histiocytic Syndrome;   Familial Hemophagocytic Lymphocytosis;   Lymphohistiocytosis;   Macrophage Activation Syndrome;   Langerhans Cell Histiocytosis (LCH);   Hemoglobinopathies;   Sickle Cell Disease;   Sickle Cell-beta-thalassemia
Intervention: Biological: CD34 Stem Cell Selection Therapy
20 Recruiting Safety and Virologic Effect of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously to HIV-Infected Adults
Condition: HIV-1
Intervention: Biological: VRC-HIVMAB080-00-AB (VRC01LS)

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.